Unrestricted Somatic Stem Cells (USSC) from Umbilical Cord Blood

Confrence News update: Orthobiologics Meeting, 10 & 11 June 2010 (pdf)

(click on the according project for further details)
Project A1
Analysis of the developmental
potential of USSC
Project A2
USSC differentiation into neuronal / glial cell types
Project A3
Reprogramming and
dedifferentiation of USSC
to germ cells
Project A4
Cell fate regulations, transcription factor and
microRNA profiles of USSC
Project A5
Epigenetic changes in
differentiation of USSC
Project Z
(click on the according project for further details)

 
Aims of the DFG – Research – Group 717

All projects jointly focus on the systematic functional and molecular analysis of the USSC.

First priority:
Exact definition of halmark properties of USSC. The ability to balance self renewal and differentiation in all three germ layers as well as germline tissue. This issue need solid functional assesment of in vitro, in vivo and microenvironmental influence, if possible at the clonal level.

This is the task of projects Z, A1, A2 and A3.

Second priority:
How are halmark properties of stem cells geneticaly regulated in the USSC.
Molecular dissection of cell fate regulation at multiple levels as they occur in time.
This is addressed in project A3, A4 and A5 with project Z providing cells and readout systems.

Resolving the biological potential of this multi- / pluri-potent human model stem cell uniquely integrates all six projects of FOR 717.


back to topback to top    


Project leaders
Speaker : P.Wernet
Co-speakers : G. Kögler / J. Schrader
 
Z G. Kögler
Inst. for Transplantation Diagnostics and Cell Therapeutics, HHU Düsseldorf
A1 J. Schrader
Inst. for Cardiovascular Physiology, HHU Düsseldorf
A2 H.W. Müller
Dept. of Neurology, HHU Düsseldorf

K. Gottmann
Inst. for Neuro- und Sensory Physiology, HHU Düsseldorf

C. Rose
Inst. for Neurobiology, HHU Düsseldorf
A3 H. Schöler
T. Cantz
Max-Planck-Institute for Molecular Biomedicine, Münster
A4 P. Wernet
B. Giebel
I. Trompeter
Inst. for Transplantation Diagnostics and Cell Therapeutics, HHU Düsseldorf

M. Müschen
Norris Comprehensive Cancer Center, USC, L.A. (USA)
A5 M. Uhrberg
S. Santourlidis
Inst. for Transplantation Diagnostics and Cell Therapeutics, HHU Düsseldorf

back to topback to top